OR

Browse By

A phase 3 open-label study of the safety and efficacy of Adalimumab in subjects with moderate to severe Hidradenitis Suppurativa (2013–2016)

Grant type:
ABBVIE Pty Ltd
Researchers:

  • Professor Peter Soyer

    MRFF-NG Practitioner Fellow
    Frazer Institute
    Faculty of Medicine
    MRFF-NG Practitioner Fellow
    Frazer Institute
    Faculty of Medicine

  • Associate Professor Erin McMeniman

    Principal Research Fellow
    Frazer Institute
    Faculty of Medicine
    ATH - Associate Professor
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
Funded by:
ABBVIE Pty Ltd